U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula CrO4.2Na
Molecular Weight 160.9219
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM CHROMATE CR-51

SMILES

[Na+].[Na+].[O-][51Cr]([O-])(=O)=O

InChI

InChIKey=PXLIDIMHPNPGMH-PJWPDVOUSA-N
InChI=1S/Cr.2Na.4O/q;2*+1;;;2*-1/i1-1;;;;;;

HIDE SMILES / InChI

Molecular Formula CrO4
Molecular Weight 114.9424
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Chromate ion CR-51 is a radioactive chromium 51 in the form of sterile, nonpyrogenic aqueous solution of sodium chromate. It is a diagnostic radiopharmaceutical for intravenous administration. This agent provides Chromium 51 decays by electron capture and gamma emission with a physical half-life of 27.7 days. It is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss. No adverse reactions specifically attributable to Chromate ion CR-51 injection have been reported.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
SODIUM CHROMATE CR 51

Approved Use

Cr51 is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss

Launch Date

6.2208E10
Diagnostic
SODIUM CHROMATE CR 51

Approved Use

Cr51 is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss

Launch Date

6.2121599E10
Diagnostic
SODIUM CHROMATE CR 51

Approved Use

Cr51 is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss

Launch Date

6.2121599E10

Sample Use Guides

The usual doses to the average patient (70 kg) are as follows: Determination of red blood cell volume or mass–0.37 to 1.11 megabecquerels (10 to 30 microcuries). Study of red blood cell survival time–5.55 megabecquerels (150 microcuries). Evaluation of blood loss–7.40 megabecquerels (200 microcuries).
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:48:31 UTC 2023
Edited
by admin
on Fri Dec 15 15:48:31 UTC 2023
Record UNII
XI776WYU0N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM CHROMATE CR-51
ORANGE BOOK  
Common Name English
SODIUM CHROMATE,CR-51 [VANDF]
Common Name English
SODIUM CHROMATE CR 51 [MI]
Common Name English
SODIUM CHROMATE (51 CR)
WHO-DD  
Common Name English
SODIUM CHROMATE CR51
Common Name English
sodium chromate (⁵¹Cr) [INN]
Common Name English
SODIUM CHROMATE CR 51
MI   USAN   USP  
USAN  
Official Name English
Sodium chromate (51 cr) [WHO-DD]
Common Name English
SODIUM CHROMATE (51CR)
INN  
INN  
Official Name English
SODIUM CHROMATE CR 51 [USAN]
Common Name English
SODIUM CHROMATE (51CR) [JAN]
Common Name English
SODIUM CHROMATE CR-51 [ORANGE BOOK]
Common Name English
SODIUM CHROMATE CR 51 [USP IMPURITY]
Common Name English
SODIUM CHROMATE, CR-51
Common Name English
Classification Tree Code System Code
NDF-RT N0000177914
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
NCI_THESAURUS C1446
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID20143241
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
MERCK INDEX
m10006
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY Merck Index
PUBCHEM
3080662
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
EVMPD
SUB15282MIG
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
LACTMED
Sodium Chromate Cr 51
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
INN
546
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
CAS
10039-53-9
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
NCI_THESAURUS
C47722
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
ChEMBL
CHEMBL2068575
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
DRUG BANK
DB09380
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
FDA UNII
XI776WYU0N
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
DRUG CENTRAL
5106
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
SMS_ID
100000078087
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY
RXCUI
91510
Created by admin on Fri Dec 15 15:48:31 UTC 2023 , Edited by admin on Fri Dec 15 15:48:31 UTC 2023
PRIMARY RxNorm
Related Record Type Details
NON-LABELED -> LABELED
Related Record Type Details
ACTIVE MOIETY